Back
Dyne Therapeutics Stock Predictions
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
17
DYN
Dyne Therapeutics
Last Price:
$9.43
Seasonality Move:
15.1%
7 Day Trial
ALL ACCESS PASS
$
7
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Dyne Therapeutics Stock Forecast
-
Over the next 52 weeks, Dyne Therapeutics has on average historically risen by 16.6% based on the past 4 years of stock performance.
-
Dyne Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Dyne Therapeutics Stock Undervalued?The current Dyne Therapeutics [DYN] share price is $9.91. The Score for DYN is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
-
DYN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Dyne Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Dyne Therapeutics has on average historically risen by 16.6% based on the past 4 years of stock performance.
Dyne Therapeutics Stock Rating
Sell
17
Dyne Therapeutics (DYN)
is a Sell
Is Dyne Therapeutics overpriced?
-
Dyne Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Dyne Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
dyne-tx.com
52-Week Data
52-Week High:
47.45
52-Week Low:
8.94
Prediction Charts
Market Cap:
1.1B
Price in USD:
9.91
Volume:
2.7M
Beta:
1.21
Technical Analysis
SMA50:
13.08
SMA100:
19.65
SMA200:
28.47
52-Wk Change:
-64.4%
Stock Predictions
-
Is Dyne Therapeutics stock public?Yes, Dyne Therapeutics is a publicly traded company.
-
What is the Dyne Therapeutics stock quote today?The Dyne Therapeutics stock price is 9.91 USD today.
-
How to buy Dyne Therapeutics stock online?You can buy Dyne Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-14 | 12.03 | 12.05 | 12.32 | 11.91 |
| Mar-17 | 12.46 | 12.31 | 12.51 | 11.82 |
| Mar-18 | 12.14 | 12.58 | 12.81 | 11.70 |
| Mar-19 | 12.54 | 12.40 | 12.62 | 12.20 |
| Mar-20 | 12.25 | 12.26 | 12.46 | 12.17 |
| Mar-21 | 12.14 | 12.08 | 12.42 | 11.69 |
| Mar-24 | 12.11 | 12.39 | 12.43 | 11.98 |
| Mar-25 | 12.42 | 11.40 | 12.42 | 11.37 |
| Mar-26 | 11.31 | 11.26 | 11.47 | 10.72 |
| Mar-27 | 11.31 | 11.80 | 11.97 | 11.26 |
| Mar-28 | 11.80 | 11.45 | 12.00 | 11.25 |
| Mar-31 | 10.70 | 10.46 | 10.90 | 9.96 |
| Apr-1 | 10.54 | 9.23 | 10.71 | 9.17 |
| Apr-2 | 9.07 | 9.91 | 10.25 | 8.94 |
Dyne Therapeutics Earnings
Dyne Therapeutics Earnings Report: Per Share Dyne Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Dyne Therapeutics Forecast Revenue Growth
Dyne Therapeutics Stock Analysis: Historical quarterly revenues per share for Dyne Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.07 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.14 per share.
* Dyne Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.